Scientist
Vaccibody AS
- Frist 30.12.2020
- Ansettelsesform Fast
Want to join our Oncology Research team?
The position
Want to join our exciting and dedicated Vaccibody team? We are currently seeking 4 scientists within the Oncology Research team where you will contribute to innovation, pre-clinical discoveries, research and development activities. Moreover, you will support ongoing pre-clinical vaccine projects and further advance novel Vaccibody vaccine technology. The ideal candidate has work experience from molecular biology, immunology and oncology, and holds a Master/PhD degree from related scientific fields.
Job responsibilities
- Initiate, plan and execute laboratory work to advance the Vaccibody vaccine technology
- Perform necessary experimental analysis and write reports
- Write and revise WINs, SOPs or other documents according to Vaccibody Quality Management System
- Establish/develop new laboratory methods at Vaccibody
- Be an active contributor in cross-functional project teams internally and/or externally
- Molecular pDNA construct design, orders and construct validation
- Cell line culturing and in vitro assays to validate the Vaccibody proteins (ELISA, Western blot, FACS)
- Primary cell culturing and Immune-assays to validate vaccine effects (ELISpot, cytotoxicity, ELISA, FACS, multiplex)
- Handling of mice, i.e., vaccination, injections of tumor challenge, bleeding, dissection of organs
- Hold internal/external presentations (both written and oral)
Who are we looking for?
When hiring new employees we look for the individuals who we think would be a good fit with our collaborative and inclusive company culture, and have qualifications that complement existing ones within the Research Oncology team. In the application letter, please highlight which of the below-mentioned “Education, experience and other qualifications” you fulfill.
Education and experience requirements
- Master/PhD degree within relevant scientific discipline
- Work experience within several of the scientific disciplines; molecular cell biology, immunology, oncology, biotechnology, microbiology, biochemistry or equivalent
- Expertise in planning, execution and reporting of research activities
- Excellent skills in Molecular Biology to design, construct and validate DNA plasmids
- Experienced with in vitro cell culturing (sterile techniques), transfections and cellular assays such as ELISA, ELISpot, FACS analysis, cytotox, proliferation, multiplex assays
- Certified FELASA C (or similar)
- Skilled with animal handling (i.m., i.p., i.v. and s.c injections, spleen, lymph-nodes and tumor dissection, collecting blood samples)
Other qualifications
- Experienced in Project lead
- Experience from vaccine/immunotherapy industry is an advantage
- Knowledge about Good Laboratory Practice (GLP)
- You are flexible, have the ability to prioritize and manage your time in cases of unforseen circumstances
- You are enthusiastic, pro-active with a positive attitude
- Enjoy working in team and wish to contribute to an excellent working environment
- You are quality-conscious, structured and accurate
- English fluency is required (working language)
- An excellent communicator both in written and verbal form
Why join our Vaccibody Team?
Vaccibody is a clinical-stage biopharmaceutical company, founded in 2007. Since then, we have become one of the world’s most exciting Biotech companies, rapidly growing, today counting almost 50 amazing employees with medical and development teams, manufacturing, bioinformatics, and research teams. We are dedicated to the discovery and development of novel immunotherapies, and are using the Vaccibody technology to generate best-in-class therapeutics to treat cancers with a high unmet medical need. Furthermore, we also focus our research on infectious diseases. We closely collaborate with Roche and Nektar Therapeutics, and are proud to have entered into a worldwide license and collaboration agreement with Genentech, a member of the Roche Group, to develop individualized neoantigen cancer vaccines.
At Vaccibody, we develop cutting-edge, targeted DNA vaccines for clinical use, based on a deep understanding of immunological principles. Vaccibody’s vaccines specifically target Antigen Presenting Cells. By intelligent design, Vaccibody’s vaccines can be tailored to induce the desired immune response profile correlating with protection for each specific disease with any given antigen.
The people at Vaccibody are at the heart of our organisation, which is why we always keep striving to offer a workplace where they can have fun and find motivation. We provide our employees with opportunities for personal growth in close collaboration with our dedicated and experienced teams. Furthermore, we ensure that proper training is provided and we support them in managing their work-life balance. Eager to learn more about our Team and our work? Please visit us at Vaccibody.com
Applications will be considered and reviewed after the deadline: December 30th.
We look forward to receive your application!
Om arbeidsgiveren
VB10.NEO, its individualized cancer neoantigen vaccines is exclusively licensed to Genentech. Vaccibody’s most advanced program (VB10.16) is a therapeutic DNA vaccine against HPV16 induced pre-malignancies and malignancies. The first in-human study (phase I/IIa), evaluating the safety and immunogenicity of VB10.16 in women with high grade cervical intraepithelial neoplasia (HSIL; CIN 2/3) has been finalized and has published positive 12 months data. Vaccibody has recently started a collaboration with Roche, exploring VB10.16 in combination with CPI atezolizumab (Tecentriq™) in up to 50 patients with advanced or recurrent cervical cancer. First patients have be vaccinated. Further, Vaccibody is exploring vaccines against infectious diseases.
- Nettverk: LinkedIn
- Sektor: Privat
- Antall stillinger: 4
- Sted: Gaustadalléen 21, 0349 Oslo
- Bransje: Forskning, utdanning og vitenskap
- Stillingsfunksjon: Annet, Forskning/Stipendiat/Postdoktor
Nøkkelord
Vaccibody, Scientist, Oncology, Immunologi, Forskning
Annonseinformasjon
- FINN-kode 200179359
- Sist endret